US Patent 10179918 Methods and compositions for increasing transgene activity

Patent 10179918 was granted and assigned to Sangamo Therapeutics on January, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Sangamo Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

101799180

Patent Inventor Names

Gregory J. Cost0

Date of Patent

January 15, 2019

Patent Application Number

151413330

Date Filed

April 28, 2016

Patent Citations Received

‌

US Patent 12123013 WPRE mutant constructs, compositions, and methods thereof

‌

US Patent 11690921 Delivery of target specific nucleases

Patent Primary Examiner

‌

Qian Janice Li

Patent abstract

Methods and compositions for increasing transgene expression and/or activity, including for increasing nuclease-mediated genomic modifications.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10179918 Methods and compositions for increasing transgene activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API